Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study)

Clinical trial NCT06584942 · COMPLETED

Trial details

NCT number: NCT06584942
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cue-reactivity Cannabis Use Disorder Functional MRI Orexin Antagonist

Start date: 2025-03-10
Primary completion: 2026-06-11
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.